Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Resectable Pancreatic Cancer × Adjuvants, Immunologic × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Resectable Pancreatic Cancer 1 Resectable Esophageal Cancer 1 Colorectal Neoplasms 1 Breast Neoplasms 1

Interventions

folfirinox 2 Gemcitabine 2 nimotuzumab 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Colony-Stimulating Factors 1 Cisplatin 1 Chemotherapy, Adjuvant 1 Chemoradiotherapy, Adjuvant 1 Adjuvants, Immunologic 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04810910 2021-11-16

Personalized Neoantigen Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy

Zhejiang Provincial People's Hospital

Phase 1 Unknown

Gastrointestinal

Resectable Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡